Unknown

Dataset Information

0

Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.


ABSTRACT:

Background

During the 2022-2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010-2011. Influenza A/H3N2 infections were predominant.

Methods

We analyzed acute respiratory illness (ARI)-associated emergency department or urgent care (ED/UC) encounters or hospitalizations at 3 health systems among children and adolescents aged 6 months-17 years who had influenza molecular testing during October 2022-March 2023. We estimated influenza A vaccine effectiveness (VE) using a test-negative approach. The odds of vaccination among influenza-A-positive cases and influenza-negative controls were compared after adjusting for confounders and applying inverse-propensity-to-be-vaccinated weights. We developed overall and age-stratified VE models.

Results

Overall, 13 547 of 44 787 (30.2%) eligible ED/UC encounters and 263 of 1862 (14.1%) hospitalizations were influenza-A-positive cases. Among ED/UC patients, 15.2% of influenza-positive versus 27.1% of influenza-negative patients were vaccinated; VE was 48% (95% confidence interval [CI], 44-52%) overall, 53% (95% CI, 47-58%) among children aged 6 months-4 years, and 38% (95% CI, 30-45%) among those aged 9-17 years. Among hospitalizations, 17.5% of influenza-positive versus 33.4% of influenza-negative patients were vaccinated; VE was 40% (95% CI, 6-61%) overall, 56% (95% CI, 23-75%) among children ages 6 months-4 years, and 46% (95% CI, 2-70%) among those 5-17 years.

Conclusions

During the 2022-2023 influenza season, vaccination reduced the risk of influenza-associated ED/UC encounters and hospitalizations by almost half (overall VE, 40-48%). Influenza vaccination is a critical tool to prevent moderate-to-severe influenza illness in children and adolescents.

SUBMITTER: Adams K 

PROVIDER: S-EPMC10954409 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccine Effectiveness Against Pediatric Influenza-A-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season: VISION Network.

Adams Katherine K   Weber Zachary A ZA   Yang Duck-Hye DH   Klein Nicola P NP   DeSilva Malini B MB   Dascomb Kristin K   Irving Stephanie A SA   Naleway Allison L AL   Rao Suchitra S   Gaglani Manjusha M   Flannery Brendan B   Garg Shikha S   Kharbanda Anupam B AB   Grannis Shaun J SJ   Ong Toan C TC   Embi Peter J PJ   Natarajan Karthik K   Fireman Bruce B   Zerbo Ousseny O   Goddard Kristin K   Timbol Julius J   Hansen John R JR   Grisel Nancy N   Arndorfer Julie J   Ball Sarah W SW   Dunne Margaret M MM   Kirshner Lindsey L   Chung Jessie R JR   Tenforde Mark W MW  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20240301 3


<h4>Background</h4>During the 2022-2023 influenza season, the United States experienced the highest influenza-associated pediatric hospitalization rate since 2010-2011. Influenza A/H3N2 infections were predominant.<h4>Methods</h4>We analyzed acute respiratory illness (ARI)-associated emergency department or urgent care (ED/UC) encounters or hospitalizations at 3 health systems among children and adolescents aged 6 months-17 years who had influenza molecular testing during October 2022-March 2023  ...[more]

Similar Datasets

| S-EPMC11306194 | biostudies-literature
| PRJEB56915 | ENA
| S-EPMC10653732 | biostudies-literature
| S-EPMC6118374 | biostudies-literature
| S-EPMC9903269 | biostudies-literature
| S-EPMC11018906 | biostudies-literature
| S-EPMC4239850 | biostudies-literature
| S-EPMC10511267 | biostudies-literature
| S-EPMC10929732 | biostudies-literature